HF
DMIIU

HRT Financial’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

HRT Financial’s Portfolio DMIIU Stock Details DMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
99,725
-275
-0.3% -$2.78K ﹤0.01% 2170
2026
Q1 		$1M Sell
100,000
-36,560
-27% -$368K ﹤0.01% 2053
2025
Q4 		$1.36M Buy
136,560
+36,560
+37% +$366K ﹤0.01% 1536
2025
Q3 		$994K Buy
+100,000
New +$997K ﹤0.01% 1521

Other funds holding DMIIU

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HRT Financial's DMIIU Position: Q2 2026 in Review

HRT Financial reduced its Drugs Made In America Acquisition II Corp Unit (DMIIU) stake by 0.28% in Q2 2026, selling an estimated $2.78K and leaving 99,725 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2170.

HRT Financial first reported a position in DMIIU in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.36M in Q4 2025. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.

  • HRT Financial held 99,725 shares of Drugs Made In America Acquisition II Corp Unit worth $1.01M as of Q2 2026.
  • HRT Financial sold 275 Drugs Made In America Acquisition II Corp Unit shares in Q2 2026, an estimated $2.78K.
  • Drugs Made In America Acquisition II Corp Unit made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2170 holding.
  • HRT Financial first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and has held it in 4 quarters since.
  • HRT Financial's Drugs Made In America Acquisition II Corp Unit position peaked at $1.36M in Q4 2025.
  • 11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.